Skip to main content
Top
Published in: Endocrine 2/2006

01-10-2006 | Case

The H723R mutation in the PDS/SLC26A4 gene is associated with typical pendred syndrome in korean patients

Authors: Mi Ae Cho, Su Jin Jeong, Sang-Mi Eom, Hyun-Yung Park, Young Joo Lee, Se Eun Park, So Young Park, Yumie Rhee, MD, PhD, Eun Soek Kang, Chul Woo Ahn, Bong Soo Cha, Eun Jig Lee, Kyung Rae Kim, Hyun Chul Lee, Sung-Kil Lim

Published in: Endocrine | Issue 2/2006

Login to get access
Metadata
Title
The H723R mutation in the PDS/SLC26A4 gene is associated with typical pendred syndrome in korean patients
Authors
Mi Ae Cho
Su Jin Jeong
Sang-Mi Eom
Hyun-Yung Park
Young Joo Lee
Se Eun Park
So Young Park
Yumie Rhee, MD, PhD
Eun Soek Kang
Chul Woo Ahn
Bong Soo Cha
Eun Jig Lee
Kyung Rae Kim
Hyun Chul Lee
Sung-Kil Lim
Publication date
01-10-2006
Publisher
Humana Press
Published in
Endocrine / Issue 2/2006
Print ISSN: 1355-008X
Electronic ISSN: 1559-0100
DOI
https://doi.org/10.1385/ENDO:30:2:237

Other articles of this Issue 2/2006

Endocrine 2/2006 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine